Initial operating campaigns are now underway at Aduro Clean Technologies Inc.'s Next Generation Process (NGP) pilot plant in London, Ontario, where the company also is headquartered. Following the ...

A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...

Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing company Seamless Therapeutics. This morning’s deal with Seamless centers on ...

Private-equity firm NGP Energy Capital Management aims to expand its investments after wrapping up a new fund and returning $2.58 billion before fees to its fund investors last year while ...

In 2018, a nervous-looking He Jiankui took the stage at a scientific conference in Hong Kong. A hush settled over the packed auditorium as the soft-spoken Chinese scientist adjusted his microphone and ...

I hate to break this to you, but every child is a genetic experiment – and nature doesn’t care if things go wrong. Our genomes are awful messes created by conflicting evolutionary forces, and every ...

Chinese automaker Xpeng has been going head to head with Tesla on multiple fronts. Like Tesla, Xpeng has been developing electric vehicles for about a decade and has expanded into areas such as ...

NGP Energy Capital Management is seeking $1.5 billion for a new fund to back entrepreneurs looking to buy and build clean-energy assets, expanding a strategy the private-equity firm has followed for ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College of Medicine and the UMass Chan Medical School have achieved ...

Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...